References
- Pournaras S, Markogiannakis A, Ikonomidis A, Kondyli L, Bethimouti K, Maniatis AN, et al. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit. J Antimicrob Chemother 2006;57:557-61 https://doi.org/10.1093/jac/dkl004
- Wilks M, Wilson A, Warwick S, Price E, Kennedy D, Ely A, et al. Control of an outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus colonization and infection in an intensive care unit (ICU) without closing the ICU or placing patients in isolation. Infect Control Hosp Epidemiol 2006;27:654-8 https://doi.org/10.1086/507011
-
Garnacho-Montero J, Ortiz-Leyba C, Jiménez-Jim
$\acute{e}$ nez FJ, Barrero-Almod$\acute{o}$ var AE, Garc$\acute{i}$ a-Garmendia JL, Bernabeu-WittelI M, et al. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis 2003;36:1111-8 https://doi.org/10.1086/374337 -
Garnacho-Montero J, Ortiz-Leyba C, Fern
$\acute{a}$ ndez-Hinojosa E, Aldab$\acute{o}$ -Pall$\acute{a}$ s T, Cayuela A, Marquez-V$\acute{a}$ caro JA, et al. Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intensive Care Med 2005;31:649-55 https://doi.org/10.1007/s00134-005-2598-0 - Lortholary O, Fagon JY, Hoi AB, Slama MA, Pierre J, Giral P, et al. Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. Clin Infect Dis 1995;20:790-6 https://doi.org/10.1093/clinids/20.4.790
- Oh SJ, Lee SU, Hwang HY, Bae IK, Jo HS, Lee BH, et al. Prevalence of class A extended-spectrum beta-lactamases in clinical isolates of acinetobacter baumannii and pseudomonas aeruginosa. Korean J Lab Med 2006;26:14-20 https://doi.org/10.3343/kjlm.2006.26.1.14
- Park AJ, Hong HR. Evaluation of methods for detection of antimicrobial resistance of Acinetobacter baumannii to Imipenem. Korean J Lab Med 2003;23:388-94
- Lee K, Lee HS, Jang SJ, Park AJ, Lee MH, Song WK, et al. Antimicrobial resistance surveillance of bacteria in 1999 in Korea with a special reference to resistance of enterococci to vancomycin and gram-negative bacilli to third generation cephalosporin, imipenem, and fluoroquinolone. J Korean Med Sci 2001;16:262-70 https://doi.org/10.3346/jkms.2001.16.3.262
- Hong SG, Lee J, Yong D, Kim EC, Jeong SH, Park YJ, et al. Antimicrobial resistance of clinically important bacteria isolated from 12 hospitals in Korea. Korean J Clin Microbiol 2004;7:171-7
- Lee H, Kim CK, Lee J, Lee SH, Ahn JY, Hong SG, et al. Antimicrobial resistance of clinically important bacteria isolated from 12 hospitals in Korea in 2005 and 2006. Korean J Clin Microbiol 2007;10:59-69
- Rios FG, Luna CM, Maskin B, Saenz Valiente A, Lloria M, Gando S, et al. Ventilator-associated pneumonia due to colistin susceptible-only microorganisms. Eur Respir J 2007;30:307-13 https://doi.org/10.1183/09031936.00156906
- Yoon J, Urban C, Terzian C, Mariano N, Rahal JJ. In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2004;48:753-7 https://doi.org/10.1128/AAC.48.3.753-757.2004
- Song JY, Kee SY, Hwang IS, Seo YB, Jeong HW, Kim WJ, et al. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 2007;60:317-22 https://doi.org/10.1093/jac/dkm136
- Tan TY, Ng LS, Tan E, Huang G. In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates. J Antimicrob Chemother 2007;60:421-3 https://doi.org/10.1093/jac/dkm178
- Motaouakkil S, Charra B, Hachimi A, Benslama A. Nosocomial pneumonia caused by multiresistant Acinetobacter baumanii treated by colistin and rifampicin. Ann Fr Anesth Reanim 2006;25:543-4 https://doi.org/10.1016/j.annfar.2006.01.006
- Sung H, Choi SJ, Yoo S, Kim MN. In vitro antimicrobial synergy against imipenem-resistant Acinetobacter baumannii. Korean J Lab Med 2007;27:111-7 https://doi.org/10.3343/kjlm.2007.27.2.111
- National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-sixth edition, M7-A6. Wayne: National Committee for Clinical Laboratory Standards; 2003
- National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-sixth edition, M2-M8. Wayne: National Committee for Clinical Laboratory Standards; 2003
- Levin AS, Barone AA, Penco J, Santos MV, Marinho IS, Arruda EA, et al. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 1999;28:1008-11 https://doi.org/10.1086/514732
- Markou N, Apostolakos H, Koumoudiou C, Athanasiou M, Koutsoukou A, Alamanos I, et al. Intravenous colistin in the treatment of sepsis from multiresistant Gramnegative bacilli in critically ill patients. Crit Care 2003;7:R78-83 https://doi.org/10.1186/cc2358
- Kasiakou SK, Michalopoulos A, Soteriades ES, Samonis G, Sermaides GJ, Falagas ME. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Antimicrob Agents Chemother 2005;49:3136-46 https://doi.org/10.1128/AAC.49.8.3136-3146.2005
- Wood GC, Hanes SD, Boucher BA, Croce MA, Fabian TC. Tetracyclines for treating multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia. Intensive Care Med 2003;29:2072-6 https://doi.org/10.1007/s00134-003-1811-2
- Holloway KP, Rouphael NG, Wells JB, King MD, Blumberg HM. Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unit. Ann Pharmacother 2006;40:1939-45 https://doi.org/10.1345/aph.1H353
- Falagas ME, Rafailidis PI, Kasiakou SK, Hatzopoulou P, Michalopoulos A. Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections. Clin Microbiol Infect 2006;12:1227-30 https://doi.org/10.1111/j.1469-0691.2006.01559.x
Cited by
- Clinical Characteristics in Patients with Carbapenem-ResistantAcinetobacter baumanniiIsolates from Tracheal Secretions vol.28, pp.3, 2013, https://doi.org/10.4266/kjccm.2013.28.3.173
- Colistin for lung infection: an update vol.3, pp.1, 2009, https://doi.org/10.1186/s40560-015-0072-9
- Intravenous polymyxins: Revival with puzzle vol.11, pp.4, 2017, https://doi.org/10.5582/bst.2017.01188
- Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis vol.73, pp.1, 2009, https://doi.org/10.1093/jac/dkx368
- Is colistin-associated acute kidney injury clinically important in adults? A systematic review and meta-analysis vol.55, pp.3, 2009, https://doi.org/10.1016/j.ijantimicag.2020.105889
- Polymyxin Monotherapy vs. Combination Therapy for the Treatment of Multidrug-resistant Infections: A Systematic Review and Meta-analysis vol.25, pp.2, 2009, https://doi.org/10.5005/jp-journals-10071-23720